Neurotoxicity from iodinated contrast agents is a known but rare complication of angiography and neurovascular intervention. Neurotoxicity results from contrast penetrating the blood-brain barrier with resultant cerebral oedema and altered neuronal excitability. Clinical effects include encephalopathy, seizures, cortical blindness and focal neurological deficits. Contrast induced encephalopathy is extensively reported as a transient and reversible phenomenon. We describe a patient with a persistent motor deficit due to an encephalopathy from iodinated contrast media administered during cerebral aneurysm coiling. This observation and a review of the literature highlights that contrast-induced encephalopathy may not always have a benign outcome and can cause permanent deficits. This potential harmful effect should be recognised by the angiographer and the interventionalist.
Fischer-WilliamsMGottschalkPGBrowellJN. Transient cortical blindness. An unusual complication of coronary angiography. Neurology. 1970; 20: 353–355.
2.
LantosG. Cortical blindness due to osmotic disruption of the blood-brain barrier by angiographic contrast material: CT and MRI studies. Neurology. 1989; 39: 567–571.
3.
AlpBNBozbugaNTuncerMA. Transient cortical blindness after coronary angiography. J Int Med Res.2009; 37: 1246–1251.
EckelTSBreiterSNMonseinLH. Subarachnoid contrast enhancement after spinal angiography mimicking diffuse subarachnoid hemorrhage. Am J Roentgenol. 1998; 170: 503–505.
6.
FangHYKuoYLWuCJ. Transient contrast encephalopathy after carotid artery stenting mimicking diffuse subarachnoid hemorrhage: A case report. Catheter Cardiovasc Interv. 2009; 73: 123–126.
7.
de LaraGarcia JVazquez-RodriguezJMSalgado-FernandezJ. [Transient cortical blindness following cardiac catheterization: An alarming but infrequent complication with a good prognosis]. Rev Esp Cardiol. 2008; 61: 88–90.
8.
GellenBRempTMayerT. Cortical blindness: A rare but dramatic complication following coronary angiography. Cardiology. 2003; 99: 57–59.
9.
GuimaraensLVivasEFonnegraA. Transient encephalopathy from angiographic contrast: A rare complication in neurointerventional procedures. Cardiovasc Intervent Radiol. 2010; 33: 383–388.
10.
HenzlovaMJCoghlanHCDeanLS. Cortical blindness after left internal mammary artery to left anterior descending coronary artery graft angiography. Cathet Cardiovasc Diagn.1988; 15: 37–39.
11.
KamataJFukamiKYoshidaH. Transient cortical blindness following bypass graft angiography. A case report. Angiology. 1995; 46: 937–946.
12.
KinnRMBreisblattWM. Cortical blindness after coronary angiography: A rare but reversible complication. Cathet Cardiovasc Diagn.1991; 22: 177–179.
13.
KocabayGKarabayCY. Iopromide-induced encephalopathy following coronary angioplasty. Perfusion. 2011; 26: 67–70.
14.
LimKKRadfordDJ. Transient cortical blindness related to coronary angiography and graft study. Med J Aust.2002; 177: 43–44.
SageMRDrayerBPDuboisPJ. Increased permeability of the blood-brain barrier after carotid Renografin-76. Am J Neuroradiol. 1981; 2: 272–274.
19.
SaigalGBhatiaRBhatiaS. MR findings of cortical blindness following cerebral angiography: Is this entity related to posterior reversible leukoencephalopathy?Am J Neuroradiol. 2004; 5: 252–256.
20.
ShynPBBellKA. Transient cortical blindness following cerebral angiography. J La State Med Soc.1989; 141: 35–37.
StuddardWEDavisDOYoungSW. Cortical blindness after cerebral angiography. Case report. J Neurosurg. 1981; 54: 240–244.
23.
TatliEBuyukluMAltunA. An unusual but dramatic complication of coronary angiography: Transient cortical blindness. Int J Cardiol. 2007; 121: e4–e6.
24.
UtzREkholmSEIsaacL. Local blood-brain barrier penetration following systemic contrast medium administration. A case report and an experimental study. Acta Radiol. 1988; 29: 237–242.
25.
ZwickerJCSilaCA. MRI findings in a case of transient cortical blindness after cardiac catheterization. Catheter Cardiovasc Interv. 2002; 57: 47–49.
26.
ShinodaJAjimiYYamadaM. Cortical blindness during coil embolization of an unruptured intracranial aneurysm-case report. Neurol Med Chir (Tokyo). 2004; 44 (8): 416–419. doi: JST.JSTAGE/nmc/44.416 [pii].
27.
NiimiYKupersmithMJAhmadS. Cortical blindness, transient and otherwise, associated with detachable coil embolization of intracranial aneurysms. Am J Neuroradiol. 2008; 29 (3): 603–607. doi: Ajnr.A0858 [pii] 10.3174/ajnr.A0858.
28.
JunckLMarshallWH. Fatal brain oedema after contrast-agent overdose. Am J Neuroradiol. 1986; 7: 522–525.
29.
ShrivastavaSMohanJCChopraP. Fatal cerebral oedema following angiocardiography: A case report. Int J Cardiol. 1985; 8: 490–491.
30.
SwanHJ. Cooperative study on cardiac catheterization. Complications involving the nervous system. Circulation. 1968; 37 (5 Suppl): III42–III45.
31.
ManiRLEisenbergRL. Complications of catheter cerebral arteriography: Analysis of 5,000 procedures. III. Assessment of arteries injected, contrast medium used, duration of procedure, and age of patient. Am J Roentgenol. 1978; 131: 871–874.
32.
de BonoD. Complications of diagnostic cardiac catheterisation: Results from 34,041 patients in the United Kingdom confidential enquiry into cardiac catheter complications. The Joint Audit Committee of the British Cardiac Society and Royal College of Physicians of London. Br Heart J.1993; 70: 297–300.
33.
UchiyamaYAbeTHirohataM. Blood brain-barrier disruption of nonionic iodinated contrast medium following coil embolization of a ruptured intracerebral aneurysm. Am J Neuroradiol. 2004; 25: 1783–1786. doi:25/10/1783 [pii].
34.
WishartDL. Complications in vertebral angiography as compared to non-vertebral cerebral angiography in 447 studies. Am J Roentgenol Radium Ther Nucl Med.1971; 113: 527–537.
35.
MuruveDASteinmanTI. Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency. Clin Nephrol. 1996; 45: 406–409.
VranckxPYsewijnTWilmsG. Acute posterior cerebral circulation syndrome accompanied by serious cardiac rhythm disturbances: A rare but reversible complication following bypass graft angiography. Catheter Cardiovasc Interv. 1999; 48: 397–401.
38.
LalliAF. Contrast media reactions: Data analysis and hypothesis. Radiology. 1980; 134: 1–12.
39.
AlmenT. Lethal doses of radiocontrast agents in laboratory animals. In: KnoefelPK ed. International encyclopedia of pharmacology and therapeutics, Appendix III. Oxford: Pergamon; 1971. p. 687–691.
40.
BaikSKKimYSLeeHJ. Immediate CT findings following embolization of cerebral aneurysms: Suggestion of blood-brain barrier or vascular permeability change. Neuroradiology. 2008; 50: 259–266. doi:10.1007/s00234-007-0332-z.
41.
BrismanJLJilaniMMcKinneyJS. Contrast enhancement hyperdensity after endovascular coiling of intracranial aneurysms. Am J Neuroradiol. 2008; 29: 588–593. doi: Ajnr.A0844 [pii] 10.3174/ajnr.A0844.
42.
OzturkASaatciIPamukAG. Focal increased cortical density in immediate postembolization CT scans of patients with intracranial aneurysms. Am J Neuroradiol. 2006; 27: 1866–1875. doi:27/9/1866 [pii].
43.
De WispelaereJFTrigauxJPVan BeersB. Cortical and CSF hyperdensity after iodinated contrast medium overdose: CT findings. J Comput Assist Tomog.1992; 16: 998–999.
44.
KuhnMJBurkTJPowellFC. Unilateral cerebral cortical and basal ganglia enhancement following over-dosage of nonionic contrast media. Comput Med Imaging Graph. 1995; 19: 307–311. doi:0895–6111(95)00008-E [pii].
45.
OkazakiHTanakaKShishidoT. Disruption of the blood-brain barrier caused by nonionic contrast medium used for abdominal angiography: CT demonstration. J Comput Assist Tomog.1989; 13: 893–895.
46.
SageMRWilsonAJ. The blood-brain barrier: An important concept in neuroimaging. Am J Neuroradiol. 1994; 15: 601–622.
47.
JunckLMarshallWH. Neurotoxicity of radiological contrast agents. Ann Neurol. 1983; 13: 469–484. doi:10.1002/ana.410130502.
48.
EarnestFTForbesGSandokBA. Complications of cerebral angiography: Prospective assessment of risk. Am J Roentgenol. 1984; 142: 247–253.
KanMKHTeraoT. Determination of iodaxamic acid (BC-17) in biological material. J Takeda Res Lab.1974; 33: 87–95.
51.
LeveyAIWeissHYuR. Seizures following myelography with iopamidol. Ann Neurol. 1988; 23: 397–399. doi:10.1002/ana.410230416.
52.
MatsudaIHJHandaH. The measurement of extravascular iodine in contrast enhancement on computed tomography. Progr Comput Tomog.1980; 2: 21–24.
53.
NakaiYHyodoAOkazakiM. [Transient cortical blindness and convulsion mimicking a hemorrhagic complication during embolization of the cerebellar AVM]. No Shinkei Geka. 1999; 27: 249–253.
54.
RapoportSIThompsonHKBidingerJM. Equi-osmolal opening of the blood-brain barrier in the rabbit by different contrast media. Acta Radiol Diagn (Stockh). 1974; 15: 21–32.
55.
SalvesenSNilsenPLHoltermannH. Effects of calcium and magnesium ions on the systemic and local toxicities of the N-methyl-glucamine (Meglumine) salt of metriozoic acid (Isopaque). Acta Radiol Diagn (Stockh). 1967; Suppl 270: 180+.
56.
WhissonCCWilsonAJEvillCA. The effect of intracarotid nonionic contrast media on the blood-brain barrier in acute hypertension. Am J Neuroradiol. 1994; 15: 95–100.
57.
AndersenPEBolstadBBergKJ. Iodixanol and ioxaglate in cardioangiography: A double-blind randomized phase III study. Clin Radiol. 1993; 48: 268–272.
58.
WilsonAJEvillCASageMR. Effects of nonionic contrast media on the blood-brain barrier. Osmolality versus chemotoxicity. Invest Radiol. 1991; 26: 1091–1094.
59.
HeymanSNClarkBAKaiserN. Radiocontrast agents induce endothelin release in vivo and in vitro.J Am Soc Nephrol. 1992; 3: 58–65.
60.
ClarkBAKimDEpsteinFH. Endothelin and atrial natriuretic peptide levels following radiocontrast exposure in humans. Am J Kidney Dis.1997; 30: 82–86.
61.
StanimirovicDBBertrandNMcCarronR. Arachidonic acid release and permeability changes induced by endothelins in human cerebromicrovascular endothelium. Acta Neurochir Suppl (Wien). 1994; 60: 71–75.
62.
YaziciMOzhanHKinayO. Transient cortical blindness after cardiac catheterization with iobitridol. Tex Heart Inst J.2007; 34: 373–375.
